These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19428794)

  • 1. Nav1.7 sodium channel-induced Ca2+ influx decreases tau phosphorylation via glycogen synthase kinase-3beta in adrenal chromaffin cells.
    Kanai T; Nemoto T; Yanagita T; Maruta T; Satoh S; Yoshikawa N; Wada A
    Neurochem Int; 2009 Jul; 54(8):497-505. PubMed ID: 19428794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nav1.7-Ca2+ influx-induced increased phosphorylations of extracellular signal-regulated kinase (ERK) and p38 attenuate tau phosphorylation via glycogen synthase kinase-3beta: priming of Nav1.7 gating by ERK and p38.
    Nemoto T; Miyazaki S; Kanai T; Maruta T; Satoh S; Yoshikawa N; Yanagita T; Wada A
    Eur J Pharmacol; 2010 Aug; 640(1-3):20-8. PubMed ID: 20470771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional up-regulation of cell surface Na V 1.7 sodium channels by insulin-like growth factor-1 via inhibition of glycogen synthase kinase-3β in adrenal chromaffin cells: enhancement of 22Na+ influx, 45Ca2+ influx and catecholamine secretion.
    Yanagita T; Satoh S; Uezono Y; Matsuo K; Nemoto T; Maruta T; Yoshikawa N; Iwakiri T; Minami K; Murakami M
    Neuropharmacology; 2011 Dec; 61(8):1265-74. PubMed ID: 21816165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homologous posttranscriptional regulation of insulin-like growth factor-I receptor level via glycogen synthase kinase-3beta and mammalian target of rapamycin in adrenal chromaffin cells: effect on tau phosphorylation.
    Nemoto T; Satoh S; Maruta T; Kanai T; Yoshikawa N; Miyazaki S; Yanagita T; Wada A
    Neuropharmacology; 2010 Jun; 58(7):1097-108. PubMed ID: 20144629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium inhibits function of voltage-dependent sodium channels and catecholamine secretion independent of glycogen synthase kinase-3 in adrenal chromaffin cells.
    Yanagita T; Maruta T; Uezono Y; Satoh S; Yoshikawa N; Nemoto T; Kobayashi H; Wada A
    Neuropharmacology; 2007 Dec; 53(7):881-9. PubMed ID: 17950380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lithium treatment up-regulates cell surface Na(V)1.7 sodium channels via inhibition of glycogen synthase kinase-3 in adrenal chromaffin cells: enhancement of Na(+) influx, Ca(2+) influx and catecholamine secretion after lithium withdrawal.
    Yanagita T; Maruta T; Nemoto T; Uezono Y; Matsuo K; Satoh S; Yoshikawa N; Kanai T; Kobayashi H; Wada A
    Neuropharmacology; 2009 Sep; 57(3):311-21. PubMed ID: 19486905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of insulin-induced PI3K/Akt/GSK-3beta and ERK signaling by neuronal nicotinic receptor/PKC-alpha/ERK pathway: up-regulation of IRS-1/-2 mRNA and protein in adrenal chromaffin cells.
    Sugano T; Yanagita T; Yokoo H; Satoh S; Kobayashi H; Wada A
    J Neurochem; 2006 Jul; 98(1):20-33. PubMed ID: 16805793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1-induced down-regulation of NaV1.7 expression in adrenal chromaffin cells: attenuation of catecholamine secretion and tau dephosphorylation.
    Nemoto T; Yanagita T; Maruta T; Sugita C; Satoh S; Kanai T; Wada A; Murakami M
    FEBS Lett; 2013 Apr; 587(7):898-905. PubMed ID: 23434582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic acid-LPA1 receptor-Rho-Rho kinase-induced up-regulation of Nav1.7 sodium channel mRNA and protein in adrenal chromaffin cells: enhancement of 22Na+ influx, 45Ca2+ influx and catecholamine secretion.
    Maruta T; Yanagita T; Matsuo K; Uezono Y; Satoh S; Nemoto T; Yoshikawa N; Kobayashi H; Takasaki M; Wada A
    J Neurochem; 2008 Apr; 105(2):401-12. PubMed ID: 18036192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of cell surface sodium channels by cyclosporin A, FK506, and rapamycin in adrenal chromaffin cells.
    Shiraishi S; Yanagita T; Kobayashi H; Uezono Y; Yokoo H; Minami SI; Takasaki M; Wada A
    J Pharmacol Exp Ther; 2001 May; 297(2):657-65. PubMed ID: 11303055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.
    Nemoto T; Kanai T; Yanagita T; Satoh S; Maruta T; Yoshikawa N; Kobayashi H; Wada A
    Eur J Pharmacol; 2008 May; 586(1-3):82-9. PubMed ID: 18395711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous increases of cytoplasmic calcium: distinct effects on down-regulation of cell surface sodium channels and sodium channel subunit mRNA levels.
    Shiraishi S; Shibuya I; Uezono Y; Yokoo H; Toyohira Y; Yamamoto R; Yanagita T; Kobayashi H; Wada A
    Br J Pharmacol; 2001 Apr; 132(7):1455-66. PubMed ID: 11264239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: the role of GSK-3beta in the maintenance of steady-state levels of insulin receptor signaling molecules and Na(v)1.7 sodium channel in adrenal chromaffin cells.
    Nemoto T; Yanagita T; Kanai T; Wada A
    J Pharmacol Sci; 2009 Feb; 109(2):157-61. PubMed ID: 19179806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destabilization of Na(v)1.7 sodium channel alpha-subunit mRNA by constitutive phosphorylation of extracellular signal-regulated kinase: negative regulation of steady-state level of cell surface functional sodium channels in adrenal chromaffin cells.
    Yanagita T; Kobayashi H; Uezono Y; Yokoo H; Sugano T; Saitoh T; Minami S; Shiraishi S; Wada A
    Mol Pharmacol; 2003 May; 63(5):1125-36. PubMed ID: 12695541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of catecholamine secretion by amitriptyline through blockage of nicotinic receptors, sodium channels, and calcium channels in bovine adrenal chromaffin cells.
    Park TJ; Shin SY; Suh BC; Suh EK; Lee IS; Kim YS; Kim KT
    Synapse; 1998 Jul; 29(3):248-56. PubMed ID: 9635895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term differential effects of neuroprotective drug NS-7 on voltage-dependent sodium channels in adrenal chromaffin cells.
    Yokoo H; Shiraishi S; Kobayashi H; Yanagita T; Minami S; Yamamoto R; Wada A
    Br J Pharmacol; 2000 Oct; 131(4):779-87. PubMed ID: 11030728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation.
    Zhao R; Zhang Z; Song Y; Wang D; Qi J; Wen S
    J Ethnopharmacol; 2011 Feb; 133(3):1109-16. PubMed ID: 21129477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase-3beta: homologous regulation of cell surface insulin receptor level via controlling insulin receptor mRNA stability in adrenal chromaffin cells.
    Yokoo H; Nemoto T; Yanagita T; Satoh S; Yoshikawa N; Maruta T; Wada A
    J Neurochem; 2007 Dec; 103(5):1883-96. PubMed ID: 17883398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C-alpha and -epsilon down-regulate cell surface sodium channels via differential mechanisms in adrenal chromaffin cells.
    Yanagita T; Kobayashi H; Yamamoto R; Kataoka H; Yokoo H; Shiraishi S; Minami S; Koono M; Wada A
    J Neurochem; 2000 Apr; 74(4):1674-84. PubMed ID: 10737626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition by riluzole of voltage-dependent sodium channels and catecholamine secretion in adrenal chromaffin cells.
    Yokoo H; Shiraishi S; Kobayashi H; Yanagita T; Yamamoto R; Wada A
    Naunyn Schmiedebergs Arch Pharmacol; 1998 May; 357(5):526-31. PubMed ID: 9650805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.